Global X Genomics & Biotechnology ETF
GNOM
52 hedge funds and large institutions have $12.4M invested in Global X Genomics & Biotechnology ETF in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 23 reducing their positions, and 11 closing their positions.
2.1% less ownership
Funds ownership: 9.08% → 6.98% (-2.1%)
12% less funds holding
Funds holding: 59 → 52 (-7)
34% less capital invested
Capital invested by funds: $18.7M → $12.4M (-$6.29M)
35% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 23
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $103K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
+$650K |
| 2 |
LPL Financial
San Diego,
California
|
+$408K |
| 3 |
Two Sigma Investments
New York
|
+$205K |
| 4 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$161K |
| 5 |
IA
Insight Advisors
Newtown,
Pennsylvania
|
+$153K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCM
One Capital Management
Westlake Village,
California
|
-$2.6M |
| 2 |
PGA
Portland Global Advisors
Portland,
Maine
|
-$2.15M |
| 3 |
Mirae Asset Global ETFs Holdings
Causeway Bay,
Hong Kong
|
-$1.06M |
| 4 |
Jane Street
New York
|
-$884K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$422K |
GNOM Hedge Fund Activity: Q2 2025 in Review
52 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q2 2025, worth a combined $12.4M — down 34% from $18.7M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of GNOM and 5 opened new positions — a net loss of 6 holders — while 23 trimmed existing stakes and 15 added.
The largest buyer was Flow Traders U.S., adding an estimated $650K. The largest seller was One Capital Management, cutting an estimated $2.6M.
- 52 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q2 2025, down from 59 in Q1 2025.
- Funds reported $12.4M of Global X Genomics & Biotechnology ETF stock for Q2 2025, down 34% quarter-over-quarter.
- 5 funds opened new Global X Genomics & Biotechnology ETF positions in Q2 2025 and 11 closed out, a net change of -6 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q2 2025 was Flow Traders U.S., an estimated $650K added.
- The largest Global X Genomics & Biotechnology ETF seller in Q2 2025 was One Capital Management, an estimated $2.6M sold.
Based on aggregated 13F filings for Q2 2025.